Ultra-Low-Dose Radiation Appears Effective in Orbital Indolent B-Cell Lymphoma

Ultra-Low-Dose Radiation Appears Effective in Orbital Indolent B-Cell Lymphoma

header-info

Response-adapted ultra-low-dose radiation therapy (ULD RT) is effective and results in negligible toxicity in patients with orbital indolent B-cell lymphoma (BCL), according to research presented at the 2022 ASTRO Annual Meeting.